お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
1003619

世界の抗肥満薬市場の分析(2021年):新型コロナウイルス感染症(COVID-19)の影響と回復過程(2030年まで)

Antiobesity Global Market Report 2021: COVID 19 Impact and Recovery to 2030

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.33円
世界の抗肥満薬市場の分析(2021年):新型コロナウイルス感染症(COVID-19)の影響と回復過程(2030年まで)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の抗肥満薬市場について調査し、市場の概要、医薬品クラス・種類・治療タイプ・地域別の市場規模の推移と予測、新型コロナウイルス感染症(COVID-19)の市場への影響、市場成長の推進要因および阻害要因の分析、パイプライン分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 新型コロナウイルス感染症(COVID-19)の影響

第5章 市場規模と成長

  • 世界の抗肥満薬市場(実績値)
    • 市場の推進要因
    • 市場の阻害要因
  • 世界の抗肥満薬市場(予測値)
    • 市場の推進要因
    • 市場の阻害要因

第6章 抗肥満薬市場:セグメント別

  • 市場区分:医薬品クラス別(実績値・予測値)
    • 末梢性抗肥満薬
    • 中枢性抗肥満薬
  • 市場区分:種類別(実績値・予測値)
    • 医療用医薬品
    • 一般用医薬品(OTC)
  • 市場区分:治療タイプ別(実績値・予測値)
    • 単剤療法
    • 多剤併用療法

第7章 抗肥満薬市場:地域・国別

  • 市場規模:地域別(実績値・予測値)
  • 市場規模:国別(実績値・予測値)

第8章 アジア太平洋地域の抗肥満薬市場

  • 市場概要
  • 地域/市場情報・COVID-19の影響・政府イニシアチブ・規制・法人税構造・投資・主要企業など
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第9章 中国の抗肥満薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第10章 インドの抗肥満薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第11章 日本の抗肥満薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第12章 オーストラリアの抗肥満薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第13章 インドネシアの抗肥満薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第14章 韓国の抗肥満薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第15章 西欧の抗肥満薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第16章 英国の抗肥満薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第17章 ドイツの抗肥満薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第18章 フランスの抗肥満薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第19章 東欧の抗肥満薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第20章 ロシアの抗肥満薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第21章 北米の抗肥満薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第22章 米国の抗肥満薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第23章 南米の抗肥満薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第24章 ブラジルの抗肥満薬市場

  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第25章 中東の抗肥満薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第26章 アフリカの抗肥満薬市場

  • 市場概要
  • 市場規模:医薬品クラス別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)

第27章 競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • F. Hoffmann-La Roche AG,
    • GlaxoSmithKline PLC,
    • Boehringer Ingelheim GmbH,
    • Pfizer Inc.,
    • Merck & Co. Inc.,

第28章 抗肥満薬パイプライン分析

第29章 主な合併・買収

第30章 将来の見通しと潜在性の分析

第31章 付録

目次

“Antiobesity Global Market Report 2021: COVID 19 Impact and Recovery to 2030 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antiobesity drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the antiobesity drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Antiobesity Drugs Market Global Report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Drug Class: Peripherally acting anti obesity drugs; Centrally acting anti obesity drugs 2) By Type: Prescription Drugs (Rx); OTC Drugs 3) By Medication: Monotherapies; Polytherapies

Companies Mentioned: F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Boehringer Ingelheim GmbH; Pfizer Inc; Merck & Co. Inc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Anti-obesity Drugs Market Characteristics

3. Anti-obesity Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Anti-obesity Drugs

5. Anti-obesity Drugs Market Size And Growth

  • 5.1. Global Anti-obesity Drugs Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Anti-obesity Drugs Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Anti-obesity Drugs Market Segmentation

  • 6.1. Global Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Peripherally acting anti obesity drugs
  • Centrally acting anti obesity drugs
  • 6.2. Global Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prescription Drugs (Rx)
  • OTC Drugs
  • 6.3. Global Anti-obesity Drugs Market, Segmentation By Medication, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Monotherapies
  • Polytherapies

7. Anti-obesity Drugs Market Regional And Country Analysis

  • 7.1. Global Anti-obesity Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Anti-obesity Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Anti-obesity Drugs Market

  • 8.1. Asia-Pacific Anti-obesity Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Anti-obesity Drugs Market

  • 9.1. China Anti-obesity Drugs Market Overview
  • 9.2. China Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Anti-obesity Drugs Market

  • 10.1. India Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Anti-obesity Drugs Market

  • 11.1. Japan Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Anti-obesity Drugs Market

  • 12.1. Australia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Anti-obesity Drugs Market

  • 13.1. Indonesia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Anti-obesity Drugs Market

  • 14.1. South Korea Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Anti-obesity Drugs Market

  • 15.1. Western Europe Anti-obesity Drugs Market Overview
  • 15.2. Western Europe Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Anti-obesity Drugs Market

  • 16.1. UK Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Anti-obesity Drugs Market

  • 17.1. Germany Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Anti-obesity Drugs Market

  • 18.4. France Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Anti-obesity Drugs Market

  • 19.1. Eastern Europe Anti-obesity Drugs Market Overview
  • 19.2. Eastern Europe Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Anti-obesity Drugs Market

  • 20.1. Russia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Anti-obesity Drugs Market

  • 21.1. North America Anti-obesity Drugs Market Overview
  • 21.2. North America Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Anti-obesity Drugs Market

  • 22.1. USA Anti-obesity Drugs Market Overview
  • 22.2. USA Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Anti-obesity Drugs Market

  • 23.1. South America Anti-obesity Drugs Market Overview
  • 23.2. South America Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Anti-obesity Drugs Market

  • 24.1. Brazil Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Anti-obesity Drugs Market

  • 25.1. Middle East Anti-obesity Drugs Market Overview
  • 25.2. Middle East Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Anti-obesity Drugs Market

  • 26.1. Africa Anti-obesity Drugs Market Overview
  • 26.2. Africa Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Anti-obesity Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Anti-obesity Drugs Market Competitive Landscape
  • 27.2. Anti-obesity Drugs Market Company Profiles
    • 27.2.1. F. Hoffmann-La Roche AG,
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. GlaxoSmithKline PLC,
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Boehringer Ingelheim GmbH,
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Pfizer Inc.,
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Merck & Co. Inc.,
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Anti-obesity Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Anti-obesity Drugs Market

30. Anti-obesity Drugs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.